On 14 May 2013, the famous actress Angelina Jolie announced to the world that she had undergone prophylactic mastectomy (followed by a laparoscopic bilateral salpingo-oophorectomy), because she had been identified as the carrier of a BRCA1 gene mutation. The aim of our review was to explore the impact of the “Angelina Jolie Effect” on women.

Troiano, G., Cozzolino, M., Bagnoli, A., Nante, N. (2017). The "Angelina Jolie effect". EUROPEAN JOURNAL OF PUBLIC HEALTH, 27(Supplemento 3), 460-460 [10.1093/eurpub/ckx186.170].

The "Angelina Jolie effect"

Troiano, G.;Nante, N.
2017-01-01

Abstract

On 14 May 2013, the famous actress Angelina Jolie announced to the world that she had undergone prophylactic mastectomy (followed by a laparoscopic bilateral salpingo-oophorectomy), because she had been identified as the carrier of a BRCA1 gene mutation. The aim of our review was to explore the impact of the “Angelina Jolie Effect” on women.
2017
Troiano, G., Cozzolino, M., Bagnoli, A., Nante, N. (2017). The "Angelina Jolie effect". EUROPEAN JOURNAL OF PUBLIC HEALTH, 27(Supplemento 3), 460-460 [10.1093/eurpub/ckx186.170].
File in questo prodotto:
File Dimensione Formato  
726.pdf

non disponibili

Descrizione: Free full-text sul sito dell'editore
Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 1.1 MB
Formato Adobe PDF
1.1 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1036265